Scilex Holding (SCLX) Accumulated Expenses (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Accumulated Expenses of $3.9 million for Q1 2026, up 135.85% year-over-year from $1.7 million in Q1 2025, and down 98.23% quarter-over-quarter from $220.7 million in Q4 2025.
Scilex Holding (SCLX) Accumulated Expenses (2021 - 2026) Analysis & Trends
Scilex Holding's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 135.85% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (up 135.85% YoY), while the FY2025 annual figure was $220.7 million, up 14563.99% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $3.9 million, down from $220.7 million in the prior quarter.
- The five-year high for Accumulated Expenses was $220.7 million in Q4 2025, with the low at $500000.0 in Q4 2023.
- The 5-year median for Accumulated Expenses is $2.3 million (2023), against an average of $18.4 million.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses tumbled 63.73% in 2022, then surged 14563.99% in 2025.
- Scilex Holding's Accumulated Expenses stood at $1.4 million in 2022, then slumped by 63.07% to $500000.0 in 2023, then surged by 201.0% to $1.5 million in 2024, then soared by 14563.99% to $220.7 million in 2025, then sank by 98.23% to $3.9 million in 2026.
- Business Quant data shows SCLX's Accumulated Expenses at $3.9 million in Q1 2026, $220.7 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 220.69 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 6.55 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 1.92 Mn |
| Jun 30, 2023 | 2.75 Mn |
| Mar 31, 2023 | 6.68 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 3.73 Mn |